Nanologica AB (publ), headquartered in Sweden, is a pioneering company in the biotechnology sector, specialising in the development of innovative drug delivery systems and advanced materials. Founded in 2004, Nanologica has achieved significant milestones, including the successful launch of its proprietary silica-based technologies that enhance the efficacy of pharmaceuticals. The company focuses on core products such as its NLAB technology, which offers unique solutions for the controlled release of active ingredients, setting it apart in the competitive landscape. With a strong presence in Europe and expanding operations globally, Nanologica is well-positioned in the market, recognised for its commitment to research and development. Its notable achievements underscore its role as a leader in the field, driving advancements in drug formulation and delivery.
How does Nanologica AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nanologica AB (publ)'s score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nanologica AB (publ), headquartered in Sweden, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Nanologica may be in the early stages of developing its climate strategy or may not yet have established formal commitments to reduce its carbon footprint. As the company operates within an industry increasingly focused on sustainability, it is essential for Nanologica to consider setting measurable targets and engaging in initiatives that align with global climate goals. Without specific emissions data or reduction commitments, it remains unclear how the company plans to address its environmental impact in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nanologica AB (publ) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

